Form 4: Royalty Pharma CFO Sells Shares
Insider Transaction (Form 4)
Terrance P. Coyne, EVP & CFO of Royalty Pharma plc, sold 11,002 shares of common stock on August 13, 2026.
Summary
- Open-market sale: disposed of 9,230 Class A Ordinary Shares at $58.59 ($540,752) on August 13, 2026; holds 1,772 after (Indirect).
- Open-market sale: disposed of 1,772 Class A Ordinary Shares at $59.14 ($104,799) on August 13, 2026 (Indirect).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $645,551 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Terrance P. Coyne — Officer (EVP & CFO)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-13 | Open-market sale | Class A Ordinary Shares | 9,230 | $59 | $540.8K | 1,772 |
| 2026-08-13 | Open-market sale | Class A Ordinary Shares | 1,772 | $59 | $104.8K | 0 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-13 | Open-market sale (9,230 shares) |
| 2026-08-13 | Open-market sale (1,772 shares) |
Keywords
insider transaction, Form 4, RPRX, Royalty Pharma plc, bearish, Terrance P. Coyne
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.